Cardiovascular Risk Assessment

Assess your cardiovascular risk with our comprehensive Cardiovascular Risk Assessment at Marylebone Diagnostic Centre. This advanced assessment includes NGS sequencing to analyze genetic predispositions and provide personalized insights into heart disease risk factors.

Cardiovascular Risk Assessment

  • Code: MLCVR

What You Get:

  • Screens genetic mutations linked to cardiomyopathies.
  • Provides insights for personalized treatment strategies.
Cardiovascular Risk Assessment


The Cardiovascular Risk Assessment is a comprehensive evaluation designed to assess your risk factors for heart disease, including genetic predispositions through NGS sequencing.

NGS sequencing analyzes genetic markers associated with cardiovascular diseases, providing personalized insights into risk factors and potential preventive measures.

Individuals with family history of heart disease or risk factors such as high blood pressure, high cholesterol, diabetes, or obesity can benefit from this assessment. It is suitable for adults of all ages.

The assessment includes NGS sequencing to analyze genetic predispositions related to heart disease and personalized recommendations for prevention and management.

Results are typically available within a few weeks after the sample is received by the laboratory. You will receive a comprehensive report detailing your cardiovascular risk factors and recommendations.

Book Your Cardiovascular Risk Assessment Today!


Stay proactive about your heart health with our specialized Cardiomyopathies test. Whether for diagnostic purposes or genetic counseling, this test offers comprehensive insights into genetic predispositions.

Order now and take control of your heart health.

For more information or to schedule a test, contact us at Marylebone Diagnostic Centre or visit

Book Now

If the information you are looking for is not available here, please contact us. Additionally, follow us on our social media platforms for updates and more information:


LinkedIn Facebook X Instagram and YouTube.